The Impact of Simulated Forest Immersion Therapy on Pain and Anxiety in Patients Axial Spondyloarthritis (axSpA)
1 other identifier
interventional
10
1 country
1
Brief Summary
The purpose of the study is to learn about the ease of using a humidified fragrant citrus forest oil, along with a virtual simulation of a forest environment (i.e., with sights and sounds of nature using a personal tablet Surface Pro 3 with headphones, to learn more about how these two aspects of the simulated forest immersion therapy (SFIT) may improve pain, anxiety, blood-pressure, and heart rate related to Axial Spondyloarthritis. The investigators hope to learn how well SFIT may impact pain levels, feelings of calm, as well as blood- pressure and heart rate, and how participants tolerate the experience overall.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 21, 2023
CompletedFirst Submitted
Initial submission to the registry
September 26, 2023
CompletedFirst Posted
Study publicly available on registry
October 10, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2024
CompletedJuly 31, 2025
July 1, 2025
6 months
September 26, 2023
July 28, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Axial Skeleton Pain
Pain on Visual Analog Scale, Scores 0-10 with higher scores reflecting greater pain
before intervention on visit 1, directly after intervention on visit 1, and one week later
Anxiety
Anxiety as scored on STAI - State only Higher scores mean greater state anxiety, 20 items with a scoring range of 1-4 on each of them. Score is totaled and range 20-80 with higher scores reflecting higher anxiety as a state.
before intervention on visit 1, directly after intervention on visit 1, and one week later
Blood Pressure
Blood Pressure measured by Omnicron tabletop BP and HR device, used clinically, higher Blood Pressure, both systolic and diastolic pressures, measured reflect/correlate with higher anxiety or pain status. Measure range 0-240.
before intervention on visit 1, after 30 minutes of the intervention start on visit 1, directly after intervention on visit 1, and one week later
Heart Rate
Heart Rate measured by Omnicron tabletop BP and HR device, used clinically, higher Heart Rate measured reflect/correlate with higher anxiety or pain status. Measure range 0-300.
before intervention on visit 1, after 30 minutes of the intervention start on visit 1, directly after intervention on visit 1, and one week later
Feasibility Questions
Questions regarding the intervention include the tolerance of the intervention, likes and dislikes of the experience and any suggestions to make the intervention experience better.
directly after intervention on visit 1
Secondary Outcomes (2)
Bath Ankylosing Spondylitis Disease Activity Index (BASDAI)
before intervention on visit 1, directly after intervention on visit 1, and one week later
Routine Assessment of Patient Index Data 3 (RAPID3)
before intervention on visit 1, directly after intervention on visit 1, and one week later
Study Arms (2)
Group 1
ACTIVE COMPARATORHumidified Forest Oils with Limonene
Group 2
ACTIVE COMPARATORForest oils and audio-visual forest exposure
Interventions
60mls Limonene in 200mls water humidified with a diffuser and audiovisual Forest sights and sounds on Surface Pro tablet.
Eligibility Criteria
You may qualify if:
- able to read at a 5th grad level
- medically diagnosed with Axial Spondyloarthritis
- tolerate having their BP and HR taken
- average of greater than 3 on their last recorded pain assessments
- average of greater than 4 on their last BASDI recorded
- currently have an assigned Rheumatologist in their care delivery
You may not qualify if:
- history of asthma
- currently pregnant
- inability to detect common odors from commercial fragrances
- smoking within 15 minutes of the start of the intervention procedure
- known allergy to citrus aroma
- hard of hearing without assistive devices
- limited vision not corrected by eye lenses
- history of hypertension uncontrolled by medications
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Oregon Health & Science University
Portland, Oregon, 97239, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Amy Miner Ross, PhD
Oregon Health and Science University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
September 26, 2023
First Posted
October 10, 2023
Study Start
September 21, 2023
Primary Completion
March 31, 2024
Study Completion
March 31, 2024
Last Updated
July 31, 2025
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will not share